11:10 AM EDT, 06/04/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.61% to 1,415.12 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech ( EVAX ) and telecommunications operator Telefonica ( TEF ) , which rose 2% and 1.8%, respectively. They were followed by biopharmaceutical company Calliditas Therapeutics ( CALT ) and internet advertising firm Criteo ( CRTO ) , which were up 0.8% each.

The decliners from continental Europe were led by petroleum refiner Equinor ( EQNR ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which fell 4.8% and 3.4%, respectively. They were followed by biopharmaceutical companies Cellectis ( CLLS ) and MorphoSys ( MOR ) , which were down 3.1% and 2.8%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and cruise line operator Carnival (CUK), which increased 6.8% and 5.6%, respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and electricity and gas provider National Grid ( NGG ) , which were up 3.6% and 1.9%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Amarin ( AMRN ) and Adaptimmune Therapeutics ( ADAP ) , which lost 10% and 6.5%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and mining company BHP Group ( BHP ) , which dropped 5.6% and 3.1%, respectively.